Feasibility of Early Gabapentin as an Intervention for Neurorecovery

Drug
General health
Online since 3 November 2022, updated 531 days ago

About this trial

This is a trial enrolling individuals with recent (less than five days) traumatic spinal cord injuries to test the feasibility of using a drug on recovery. The drug, Gabapentin, is commonly used in spinal cord injury to manage neuropathic pain. Different doses of Gabapentin will be administered for 90 days. If included, participants will receive either a low dose of Gabapentin, a high dose of Gabapentin, or a placebo for comparison. Final testing will be performed after 6 months.

Included participants

Gender
All
Age
≥ 18 years
Injury level
C1 - S5
Time since injury
≥ null null
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    C1-S5
    Additionally, participants must
    NOT have suffered a moderate/severe traumatic brain injury (TBI)

    What’s involved

    Type

    Drug

    Details

    - Oral intake of two capsules, three times a day, for 90 days

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 14 Mar 2022
    • Organisation
    • MetroHealth Medical Center
    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 14 Mar 2022
    • Organisation
    • MetroHealth Medical Center

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more